BMY · Healthcare
Bristol-Myers Squibb Co
Smart-money confidence
· 1 of 3 sources positive
Weak — few signals
No standout activity across the feeds we track.
Hedge funds
56
Congress
No data
Insiders
No data
Cross-source blend of hedge-fund breadth, Congress trades, and insider Form 4s. ·
how the score works
◆ Next steps
Interested in BRISTOL-MYERS SQUIBB CO? Here's what to do with it.
◇
Compare with other stocks
Sort 7,111 stocks by confidence, holders, or Congress signal
◈
Backtest the strategy
See how the model has done historically before you commit real money
✉
Get the weekly digest
One email on Sunday · what changed in the model this week
Not financial advice. Bogen Capital surfaces public SEC filings — you decide what to do with them.
Market cap
$133.4B
Industry
Drug Manufacturers - General
Sector
Healthcare
Exchange
NYSE
About BRISTOL-MYERS SQUIBB CO
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company offers products for oncology, hematology, immunology, cardiovascular, and neuroscience indications. Its products include Opdivo for anti-cancer indications; Opdivo Qvantig, a subcutaneous PD-1 inhibitor for solid tumors; Orencia for active rheumatoid arthritis and psoriatic arthritis; Yervoy for the treatment of unresectable or metastatic melanoma; Reblozyl to treat anemia; Breyanzi for the treatment of relapsed or refractory large B-cell…
Who's behind the signal
Every informed buyer we can see on BMY, across all three feeds.
Hedge funds · 10
Point72 (Steve Cohen)
New position
AQR Capital Management
Increased +173%
Gotham Asset Mgmt (Greenblatt)
Increased +12%
Tweedy Browne
Increased +16%
Elliott Investment Mgmt
Unchanged
Bridgewater Associates (Dalio)
Decreased −8%
+4 more in the full breakdown below ↓
Congress · 0
No congressional trades on record.
Insiders
No significant Form 4 insider activity in the window.
Congressional trade history · 43
Every disclosed buy & sell on record — STOCK Act filings
| Trade date | Member | Chamber | Action | Amount |
|---|---|---|---|---|
| 2021-11-10 | Carol D. Miller · R-WV | House | SOLD | $15,001 - $50,000 |
| 2021-10-28 | Kim Schrier · D-WA | House | SOLD | $1,001 - $15,000 |
| 2021-02-05 | Kurt Schrader · D-OR | House | BOUGHT | $1,001 - $15,000 |
| 2020-11-19 | Kenny Marchant · R-TX | House | BOUGHT | $15,001 - $50,000 |
| 2020-10-22 | George Holding · R-NC | House | SOLD | $1,001 - $15,000 |
| 2020-10-22 | Katherine M. Clark · D-MA | House | SOLD | $1,001 - $15,000 |
| 2020-08-14 | George Holding · R-NC | House | SOLD | $1,001 - $15,000 |
| 2020-06-21 | John H. Rutherford · R-FL | House | BOUGHT | $1,001 - $15,000 |
| 2020-04-16 | David Perdue · R-GA | Senate | SOLD | $1,001 - $15,000 |
| 2020-04-14 | David Perdue · R-GA | Senate | SOLD | $15,001 - $50,000 |
| 2020-04-14 | Kelly Loeffler · R-GA | Senate | SOLD | $100,001 - $250,000 |
| 2020-04-14 | Kelly Loeffler · R-GA | Senate | SOLD | $250,001 - $500,000 |
| 2020-04-03 | Katherine M. Clark · D-MA | House | BOUGHT | $1,001 - $15,000 |
| 2020-03-18 | Gilbert Ray Cisneros, Jr. · D-CA | House | SOLD | $1,001 - $15,000 |
| 2020-03-13 | Van Taylor · R-TX | House | SOLD | $100,001 - $250,000 |
| 2020-02-20 | Mikie Sherrill · D-NJ | House | SOLD | $1,001 - $15,000 |
| 2020-01-21 | Mikie Sherrill · D-NJ | House | BOUGHT | $1,001 - $15,000 |
| 2020-01-14 | George Holding · R-NC | House | SOLD | $1,001 - $15,000 |
| 2020-01-14 | Gilbert Ray Cisneros, Jr. · D-CA | House | BOUGHT | $1,001 - $15,000 |
| 2019-12-18 | Mikie Sherrill · D-NJ | House | SOLD | $1,001 - $15,000 |
| 2019-08-15 | David Perdue · R-GA | Senate | SOLD | $15,001 - $50,000 |
| 2019-07-15 | David Perdue · R-GA | Senate | BOUGHT | $15,001 - $50,000 |
| 2018-12-28 | Sheldon Whitehouse · D-RI | Senate | SOLD | $15,001 - $50,000 |
| 2018-06-04 | James M. Inhofe · R-OK | Senate | SOLD | $50,001 - $100,000 |
| 2018-01-04 | Shelley Moore Capito · R-WV | Senate | SOLD | $1,001 - $15,000 |
| 2017-10-26 | Shelley Moore Capito · R-WV | Senate | SOLD | $1,001 - $15,000 |
| 2017-07-13 | Sheldon Whitehouse · D-RI | Senate | SOLD | $1,001 - $15,000 |
| 2017-06-15 | Patty Murray · D-WA | Senate | SOLD | $1,001 - $15,000 |
| 2017-03-22 | David Perdue · R-GA | Senate | BOUGHT | $1,001 - $15,000 |
| 2017-03-16 | Patty Murray · D-WA | Senate | BOUGHT | $1,001 - $15,000 |
| 2017-02-28 | James M. Inhofe · R-OK | Senate | SOLD | $15,001 - $50,000 |
| 2017-02-23 | Sheldon Whitehouse · D-RI | Senate | BOUGHT | $1,001 - $15,000 |
| 2017-02-01 | James M. Inhofe · R-OK | Senate | BOUGHT | $15,001 - $50,000 |
| 2017-01-20 | John Hoeven · R-ND | Senate | SOLD | $50,001 - $100,000 |
| 2016-08-22 | John Hoeven · R-ND | Senate | BOUGHT | $50,001 - $100,000 |
| 2016-08-18 | Sheldon Whitehouse · D-RI | Senate | SOLD | $1,001 - $15,000 |
| 2016-08-11 | David Perdue · R-GA | Senate | BOUGHT | $1,001 - $15,000 |
| 2016-08-08 | James M. Inhofe · R-OK | Senate | BOUGHT | $15,001 - $50,000 |
| 2015-02-23 | Sheldon Whitehouse · D-RI | Senate | BOUGHT | $1,001 - $15,000 |
| 2014-10-14 | Sheldon Whitehouse · D-RI | Senate | BOUGHT | $1,001 - $15,000 |
| 2014-09-18 | Sheldon Whitehouse · D-RI | Senate | BOUGHT | $1,001 - $15,000 |
| 2014-07-15 | Sheldon Whitehouse · D-RI | Senate | BOUGHT | $1,001 - $15,000 |
| 2014-06-19 | Susan M. Collins · R-ME | Senate | SOLD | $1,001 - $15,000 |
Not a model pick — but on our radar.
BRISTOL-MYERS SQUIBB CO isn't in the top-10 model right now, but 10 tracked investors hold it. Everything below is real signal from public filings — treat this as a watch candidate, not a conviction call.
10
Investors
1
New positions
3
Increasing
5
Decreasing
1
Unchanged
Price History
Loading price data...
Return:
High:
Low:
Who's Holding This Stock
Position sizes and recent activity from tracked institutional investors
Trust weight: 1.1×
% of portfolio
0.3%
Position change
NEW
0.3% of Point72's portfolio
Trust weight: 1.0×
% of portfolio
0.7%
Position change
+173%
0.7% of AQR Capital Management's portfolio
Trust weight: 1.1×
% of portfolio
0.1%
Position change
+12%
0.1% of Gotham Asset Mgmt's portfolio
Trust weight: 1.2×
% of portfolio
0.1%
Position change
+16%
0.1% of Tweedy Browne's portfolio
Trust weight: 1.3×
% of portfolio
0.2%
Position change
—
0.2% of Elliott Investment Mgmt's portfolio
Trust weight: 1.3×
% of portfolio
0.1%
Position change
−8%
0.1% of Bridgewater Associates's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−58%
0.0% of Citadel Advisors's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−67%
0.0% of Millennium Management's portfolio
Trust weight: 1.2×
% of portfolio
0.0%
Position change
−97%
0.0% of Tudor Investment's portfolio
Trust weight: 1.0×
% of portfolio
0.0%
Position change
−79%
0.0% of D.E. Shaw & Co's portfolio
Portfolio Allocation
How much of each investor's portfolio is allocated to BRISTOL-MYERS SQUIBB CO
⚠ Disclaimer: This page is for informational purposes only. Holdings data from SEC EDGAR 13F filings, delayed up to 135 days. Not a recommendation to buy or sell BRISTOL-MYERS SQUIBB CO or any security.
Get the Weekly Update
Every Sunday, we'll send you what Buffett, Dalio, Ackman and 47 other legendary investors are buying — free, straight from their SEC filings.
Free forever · No spam · Unsubscribe anytime